Hash Labs Inc. is a Nevada corporation that was originally formed on November 1, 2005 when Bio-Solutions International Inc. (“Bio-Solutions”) entered into an Agreement and Plan of Merger with OmniMed Acquisition Corp., a Nevada corporation and a wholly-owned subsidiary of Bio-Solutions, OmniMed International Inc. (“OmniMed”) and the shareholders of OmniMed. On January 17, 2006, OmniMed changed its name to MedeFile International Inc. The Company’s business following the closing of this agreement was the sale of an Internet-enabled Personal Health Record (iPHR) system for gathering, digitizing, maintaining, accessing and sharing an individual’s medical records, and in connection therewith, providing a professional service specializing in HIPAA compliant retrieval, reproduction and release of information. Under this service, Company personnel went onsite to physicians’ offices weekly to reproduce the records requested by third parties.
Company profile
Ticker
CGLO
Exchange
Website
CEO
J. Mark Goode
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
Microsoft • Oracle • Mobileye Global • Gen Digital • Activision Blizzard • BlackBerry • Vmware • Adobe • Salesforce • Ceridian HCM Holding ...
Former names
BIO SOLUTIONS INTERNATIONAL INC, Hash Labs Inc., Medefile International, Inc., OMNIMED INTERNATIONAL, INC., SEPTIMA ENTERPRISES INC, Tech Town Holdings Inc.
SEC CIK
Corporate docs
Subsidiaries
Coro Corp. ...
IRS number
850368333
CGLO stock data
Latest filings (excl ownership)
8-K
Coro Global Responds to Recent Request for a Special Meeting of Stockholders
1 Oct 21
8-K
Departure of Directors or Certain Officers
10 Sep 21
10-Q
2021 Q2
Quarterly report
23 Aug 21
NT 10-Q
Notice of late quarterly filing
16 Aug 21
10-Q
2021 Q1
Quarterly report
20 May 21
NT 10-Q
Notice of late quarterly filing
17 May 21
RW
Registration withdrawal request
5 May 21
10-K
2020 FY
Annual report
31 Mar 21
S-1/A
IPO registration (amended)
26 Jan 21
8-K
Entry into a Material Definitive Agreement
21 Jan 21
Latest ownership filings
No filings
Financial summary
| Quarter (USD) | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 881.13 k | 881.13 k | 881.13 k | 881.13 k | 881.13 k | 881.13 k |
| Cash burn (monthly) | 255.25 k | 16.48 k | 272.90 k | 377.99 k | 255.25 k | 261.52 k |
| Cash used (since last report) | 5.89 mm | 380.63 k | 6.30 mm | 8.73 mm | 5.89 mm | 6.04 mm |
| Cash remaining | -5.01 mm | 500.50 k | -5.42 mm | -7.85 mm | -5.01 mm | -5.16 mm |
| Runway (months of cash) | -19.6 | 30.4 | -19.9 | -20.8 | -19.6 | -19.7 |
Institutional ownership, Q2 2021
| 13F holders | Current |
|---|---|
| Total holders | 0 |
| Opened positions | 0 |
| Closed positions | 1 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 0.00 |
| Total shares | 0.00 |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|